<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0290">
 <label>57</label>
 <element-citation publication-type="journal" id="rf0280">
  <person-group person-group-type="author">
   <name>
    <surname>Gilbert</surname>
    <given-names>B.E.</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Guebre-Xabier</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Piedra</surname>
    <given-names>P.A.</given-names>
   </name>
  </person-group>
  <article-title>Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge</article-title>
  <source>Vaccine</source>
  <volume>36</volume>
  <issue>52</issue>
  <year>2018</year>
  <fpage>8069</fpage>
  <lpage>8078</lpage>
  <ext-link ext-link-type="uri" xlink:href="pmid:30389195" id="ir0365" xmlns:xlink="http://www.w3.org/1999/xlink">30389195</ext-link>
  <pub-id pub-id-type="pmid">30389195</pub-id>
 </element-citation>
</ref>
